SynthesisHematological oncology2025

Daratumumab, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide, and Dexamethasone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: A Systematic Literature Review and Meta-Analysis.

Lucio N Gordan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.